Prior to the introduction of CFTR modulators in CF health care, people with CF (pwCF) were highly medicated with antibiotics to combat recurrent or chronic infections, by this ultimately aggravating CF-linked dysbiosis and selection for pathogens such as Staphylococcus aureus and Pseudomonas aeruginosa. This evidence concerns the gene CFTR and cystic fibrosis.